Darolutamide gets marketing authorization in Japan

The Japanese Ministry of Health, Labor and Welfare (MHLW) has granted marketing authorization for darolutamide, under th...

January 24, 2020 | Friday | News
RegeneRx Biopharma receives patent in Korea

US based RegeneRx Biopharmaceuticals, a clinical-stage drug development company focused on tissue protection, repai...

January 23, 2020 | Thursday | News
Hitachi Chemical inks pact with Ori Biotech

Hitachi Chemical Advanced Therapeutics Solutions, LLC,  a US subsidiary of Japanese firm Hitachi Chemical Co., Ltd....

January 23, 2020 | Thursday | News
PhoreMost, Otsuka collaborate for multi drug discovery projects

PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease target...

January 22, 2020 | Wednesday | News
ViiV Healthcare wins Japanese approval for Dovato to treat HIV-1

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as share...

January 20, 2020 | Monday | News
InterVenn Biosciences advances glycoproteomics for complex disease therapies

US based InterVenn Biosciences has announced multiple achievements in its development of AI-enabled glycoproteomics, as ...

January 17, 2020 | Friday | News
Charles River inks scientific collaboration with Takeda

US based company Charles River has announced a multi-year drug discovery collaboration with Japanese firm Takeda Pharmac...

January 16, 2020 | Thursday | News
Hitachi starts commercial manufacturing of Zynteglo

apceth Biopharma GmbH, a subsidiary of Japan headquartered Hitachi Chemical Co., Ltd. and a leading company for the manu...

January 15, 2020 | Wednesday | News
FDA approves sNDA for Astellas’s antifungal drug

Japan based Astellas Pharma Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved its supplem...

January 13, 2020 | Monday | News
China approves AstraZeneca’s Lokelma to treat hyperkalaemia

AstraZeneca’s Lokelma (sodium zirconium cyclosilicate) has been approved in China for the treatment of a...

January 7, 2020 | Tuesday | News
China grants priority review to Luye Pharma's schizophrenia drug

Luye Pharma Group has announced that the New Drug Application (NDA) for Risperidone Extended-Release Microspheres for In...

January 2, 2020 | Thursday | News
AstraZeneca’s triple-combination therapy gets approval in China for COPD

AstraZeneca has announced that budesonide/glycopyrronium/formoterol fumarate has been approved in China for the maintena...

January 1, 2020 | Wednesday | News
Luye Pharma seeks USFDA approval for antidepressant drug

China based Luye Pharma Group has announced submission of a new drug application (NDA) to the U.S. Food and Drug Adminis...

December 30, 2019 | Monday | News
USFDA approves Daiichi Sankyo and AstraZeneca’s breast cancer drug

Daiichi Sankyo and AstraZeneca have announced that the U.S. Food and Drug Administration (FDA) has approved ENHERTU®...

December 26, 2019 | Thursday | News
Allergan gets FDA nod for acute migraine treatment

The U.S. Food and Drug Administration has approved Ubrelvy (ubrogepant) tablets for the acute (immediate) treatment of m...

December 24, 2019 | Tuesday | News
Eisai gets USFDA nod for insomnia drug

Eisai has announced that the U.S. Food and Drug Administration (FDA) approved DAYVIGO™ (lemborexant) 5 mg and...

December 24, 2019 | Tuesday | News
BeiGene cancer drug misses mark in Phase III study

China based BeiGene,  a commercial-stage biopharmaceutical company focused on developing and commercializing innova...

December 20, 2019 | Friday | News
Takeda, Turnstone Biologics to develop novel viral immunotherapies

US based Turnstone Biologics, a biotechnology company pioneering the development of engineered viral immunotherapies,&nb...

December 20, 2019 | Friday | News